Kang, Elizabeth M

The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications. [electronic resource] - Current hematology reports Jul 2004 - 274-81 p. digital

Publication Type: Journal Article; Review

1540-3408


Animals
Child
Genetic Therapy--adverse effects
Genetic Vectors--adverse effects
Hematopoietic Stem Cells--metabolism
Humans
Leukemia--etiology
Retroviridae--genetics
Severe Combined Immunodeficiency--complications
Treatment Outcome
Virus Integration